These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7963722)

  • 1. Tetravalent rhesus rotavirus vaccine in young infants.
    Kobayashi M; Thompson J; Tollefson SJ; Reed GW; Wright PF
    J Infect Dis; 1994 Nov; 170(5):1260-3. PubMed ID: 7963722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
    Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
    J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Wasserman SS; Glass RI; Keane VA
    Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
    Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
    J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.
    Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET
    Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
    Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
    Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.
    Flores J; Perez-Schael I; Blanco M; White L; Garcia D; Vilar M; Cunto W; Gonzalez R; Urbina C; Boher J
    Lancet; 1990 Aug; 336(8711):330-4. PubMed ID: 1975333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine.
    Ing DJ; Glass RI; Woods PA; Simonetti M; Pallansch MA; Wilcox WD; Davidson BL; Sievert AJ
    Am J Dis Child; 1991 Aug; 145(8):892-7. PubMed ID: 1650128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
    Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
    Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
    Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh.
    Bresee JS; El Arifeen S; Azim T; Chakraborty J; Mounts AW; Podder G; Gentsch JR; Ward RL; Black R; Glass RI; Yunus M
    Pediatr Infect Dis J; 2001 Dec; 20(12):1136-43. PubMed ID: 11740320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
    Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
    Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants.
    Migasena S; Simasathien S; Samakoses R; Pitisuttitham P; Sangaroon P; van Steenis G; Beuvery EC; Bugg H; Bishop R; Davidson BL
    Vaccine; 1995 Feb; 13(2):168-74. PubMed ID: 7625111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants.
    Pichichero ME; Marsocci SM; Francis AB; Green JL; Disney FA; Rennels MB; Lewis ED; Sugarman L; Losonsky GA; Zito E
    Vaccine; 1993; 11(7):747-53. PubMed ID: 8393606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field trial of rhesus rotavirus vaccine in infants.
    Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
    Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Ward RL; Mack ME; Zito ET
    J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J; Koskenniemi E; Pang XL; Vesikari T
    Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.